Press Release Summary:
With treated diatomaceous earth stationary phase and formats to handle a number of sample volumes, HyperSep(TM) SLE facilitates processing and extraction of samples from complex biological matrices. Solution offers chromatographic sample preparation option, and functionality enables sample background reduction for improved concentration on desired analytes. Solid supported liquid/liquid extraction (SLE) solution also promotes analyte purity and can prevent complications.
Original Press Release:
Thermo Fisher Scientific Expands Sample Preparation Portfolio
Thermo Scientific HyperSep SLE Range Provides Greater Sample Purity from Biological Samples ATLANTA - Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific HyperSep SLE chromatographic sample preparation option for processing and simplifying extraction of samples from complex biological matrices. The new sample preparation format offers a fast, effective method to reduce sample background and concentrate the desired analytes. The HyperSep(TM) SLE technology gives greater reproducibility and reliability in sample preparation compared to Liquid/Liquid Extraction (LLE). And, unlike protein precipitation techniques, it removes contaminants such as phospholipids. The solid supported liquid/liquid extraction (SLE) solution offered by HyperSep SLE also provides a platform for greater automation and analyte purity, reduces solvent requirements and can prevent complications such as emulsification of the separate phases. Biological samples are frequently in the form of complex liquids that contain a wide variety of compounds and chemistries. Reducing the complexity of the sample matrix significantly diminishes background interferences, and this increases the sensitivity of the separations technique. With a treated diatomaceous earth stationary phase, and formats to handle a number of sample volumes, the HyperSep SLE range provides optimized solutions for sample extraction from biological matricies. For more information about the Thermo Scientific HypSep SLE portfolio, please visit www.thermoscientific.com/SPE. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of nearly $11 billion, we have approximately 37,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com.